Dana E Lowry1, Daniel J Corsi2. 1. Ottawa Hospital Research Institute (Lowry, Corsi), University of Ottawa; Faculty of Medicine (Corsi), School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ont. 2. Ottawa Hospital Research Institute (Lowry, Corsi), University of Ottawa; Faculty of Medicine (Corsi), School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ont. dcorsi@ohri.ca.
Abstract
BACKGROUND: Cannabis is the most widely used drug in Canada. We examined the trends in past-year cannabis consumption by sociodemographic and geographic characteristics. METHODS: We conducted a repeated cross-sectional analysis of the Canadian Tobacco Use Monitoring Survey, the Canadian Tobacco, Alcohol and Drugs Survey and the Canadian Alcohol and Drug Use Monitoring Survey from 2004 to 2017. Respondents were aged 15 years and older. Past-year cannabis use was analyzed using multivariable logistic regression and segmented logistic regression. RESULTS: We analyzed 289 823 respondents (51% female) between 2004 and 2017. Between 2004 and 2017, the overall prevalence of cannabis use increased from 12.2% (95% confidence interval [CI] 11.0%-13.5%) to 18.7% (95% CI 16.2%-21.5%) among men and from 6.6% (95% CI 5.9%-7.4%) to 11.1% (95% CI 9.4%-13.0%) among women. The crude rate of change was greater between 2011 and 2017 than that between 2004 and 2011 in men (odds ratio [OR] per annual change: 1.08, 95% CI 1.05-1.11) and women (OR 1.11, 95% CI 1.07-1.15). After adjustment for age, education, tobacco smoking and province, the 2011-2017 trend was stronger in men (adjusted OR 1.24, 95% CI 1.05-1.46), but not in women (adjusted OR 1.13, 95% CI 0.93-1.37). Cannabis use was associated with tobacco smoking (OR 4.94, 95% CI 4.65-5.25). Heterogeneity was found in cannabis use trends by age, education and province. Cannabis use decreased among respondents aged 15-19 years and increased in other age groups. INTERPRETATION: Cannabis consumption in Canada has increased and varies by sex, age, level of education and geography. Increases vary by sociodemographic factors and may be faster among certain groups. Further studies are warranted post-legalization. Copyright 2020, Joule Inc. or its licensors.
BACKGROUND: Cannabis is the most widely used drug in Canada. We examined the trends in past-year cannabis consumption by sociodemographic and geographic characteristics. METHODS: We conducted a repeated cross-sectional analysis of the Canadian Tobacco Use Monitoring Survey, the Canadian Tobacco, Alcohol and Drugs Survey and the Canadian Alcohol and Drug Use Monitoring Survey from 2004 to 2017. Respondents were aged 15 years and older. Past-year cannabis use was analyzed using multivariable logistic regression and segmented logistic regression. RESULTS: We analyzed 289 823 respondents (51% female) between 2004 and 2017. Between 2004 and 2017, the overall prevalence of cannabis use increased from 12.2% (95% confidence interval [CI] 11.0%-13.5%) to 18.7% (95% CI 16.2%-21.5%) among men and from 6.6% (95% CI 5.9%-7.4%) to 11.1% (95% CI 9.4%-13.0%) among women. The crude rate of change was greater between 2011 and 2017 than that between 2004 and 2011 in men (odds ratio [OR] per annual change: 1.08, 95% CI 1.05-1.11) and women (OR 1.11, 95% CI 1.07-1.15). After adjustment for age, education, tobacco smoking and province, the 2011-2017 trend was stronger in men (adjusted OR 1.24, 95% CI 1.05-1.46), but not in women (adjusted OR 1.13, 95% CI 0.93-1.37). Cannabis use was associated with tobacco smoking (OR 4.94, 95% CI 4.65-5.25). Heterogeneity was found in cannabis use trends by age, education and province. Cannabis use decreased among respondents aged 15-19 years and increased in other age groups. INTERPRETATION: Cannabis consumption in Canada has increased and varies by sex, age, level of education and geography. Increases vary by sociodemographic factors and may be faster among certain groups. Further studies are warranted post-legalization. Copyright 2020, Joule Inc. or its licensors.
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: J Clin Epidemiol Date: 2008-04 Impact factor: 6.437
Authors: Daniel J Corsi; Laura Walsh; Deborah Weiss; Helen Hsu; Darine El-Chaar; Steven Hawken; Deshayne B Fell; Mark Walker Journal: JAMA Date: 2019-07-09 Impact factor: 56.272
Authors: Devika Chawla; Yang C Yang; Tania A Desrosiers; Daniel J Westreich; Andrew F Olshan; Julie L Daniels Journal: Drug Alcohol Depend Date: 2018-10-17 Impact factor: 4.492
Authors: Kira Bombay; Malia S Q Murphy; Kathryn M Denize; Ayni Sharif; Lindsey Sikora; Rebecca Murray; Kelly D Cobey; Daniel J Corsi Journal: BMJ Open Date: 2021-02-05 Impact factor: 2.692
Authors: Liam Cresswell; Lisette Espin-Noboa; Malia S Q Murphy; Serine Ramlawi; Mark C Walker; Márton Karsai; Daniel J Corsi Journal: JMIR Res Protoc Date: 2022-03-29
Authors: Taylor McGuckin; Mark A Ferro; David Hammond; Shannon Stewart; Bridget Maloney-Hall; Nawaf Madi; Amy Porath; Christopher M Perlman Journal: Can J Psychiatry Date: 2020-12-31 Impact factor: 4.356